PRESS RELEASE published on 02/26/2025 at 00:05, 11 months 4 days ago 1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million 1933 Industries Inc. announces fourth quarter and fiscal year 2024 financial results, with record revenues, gross profit increase, and net loss reduction. The company focuses on cannabis cultivation in Nevada Financial Results Nevada Record Revenues 1933 Industries Inc. Cannabis Cultivation
PRESS RELEASE published on 02/26/2025 at 00:00, 11 months 4 days ago MedMira Announces Exclusive Distribution Agreement with Trimedic Inc. for Canada MedMira Inc. (TSXV:MIR) partners with Trimedic Inc. for exclusive distribution of Multiplo® TP/HIV and Reveal® G4 HIV-1/2 rapid antibody tests in Canada, aiming to improve access to rapid diagnostic testing solutions Distribution Agreement MedMira Inc. Point-of-Care Diagnostics Trimedic Inc. Rapid Antibody Tests
PRESS RELEASE published on 02/25/2025 at 23:35, 11 months 4 days ago Pinetree Capital Ltd Announces Audited Financial Results for the Year Ended December 31, 2024 Pinetree Capital Ltd. announces financial results for the year ended December 31, 2024, with equity increasing by 71% and net investment gains of $17,788 for the three months ended December 31, 2024 Financial Results Technology Sector Pinetree Capital Ltd. Equity Increase Net Investment Gains
PRESS RELEASE published on 02/25/2025 at 23:03, 11 months 4 days ago Inside Information / Other news releases Teva and Medincell announce FDA acceptance of UZEDY(R) risperidone for bipolar I disorder treatment, expanding indications for this long-acting injectable antipsychotic FDA Medincell Teva UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 23:03, 11 months 4 days ago Informations privilégiées / Autres communiqués Teva et Medincell annoncent l'acceptation par la FDA d'une demande de nouveau médicament supplémentaire pour UZEDY® en tant que traitement du trouble bipolaire I FDA Medincell Teva UZEDY Bipolar I Disorder
PRESS RELEASE published on 02/25/2025 at 22:47, 11 months 4 days ago abrdn Emerging Markets Ex-China Fund, Inc. (AEF) Announces Final Results of Cash Tender Offer abrdn Emerging Markets Equity ex-China Fund, Inc. announced final results of cash tender offer, accepting 10,150,355 shares for $6.07 per share, subject to proration. Fund's name changed with new investment strategy Investment Strategy Emerging Markets Cash Tender Offer Abrdn NYSE American
PRESS RELEASE published on 02/25/2025 at 22:30, 11 months 4 days ago Transforming Network Operations: Amdocs Unveils Cognitive RAN Automation Platform and rApp Ecosystem at MWC 2025 Amdocs announces the launch of its vendor-neutral platform, Amdocs Cognitive RAN Automation, leveraging AI-driven tech for network management and optimization for communication service providers Amdocs AI-driven Technology Network Management Cognitive RAN Automation Vendor-neutral Platform
PRESS RELEASE published on 02/25/2025 at 22:01, 11 months 4 days ago DBV Technologies participera au prochain congrès conjoint AAAAI/WAO DBV Technologies participera au prochain congrès conjoint AAAAI/WAO en présentant les résultats de l'étude sur l'immunothérapie épicutanée avec VIASKIN® peanut pour les enfants allergiques à l'arachide Immunothérapie DBV Technologies Viaskin Peanut Congrès Conjoint AAAAI/WAO
PRESS RELEASE published on 02/25/2025 at 22:01, 11 months 4 days ago DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress DBV Technologies to participate in AAAAI/WAO Joint Congress to present long-term efficacy results of epicutaneous immunotherapy with VIASKIN peanut patch in peanut-allergic children aged 4-11 years, showcasing treatment benefits and high compliance rates DBV Technologies Epicutaneous Immunotherapy Viaskin Peanut Patch AAAAI/WAO Joint Congress PEPITES Study
REGULATED PRESS RELEASE published on 02/25/2025 at 20:57, 11 months 4 days ago Entech : Chiffre d’affaires annuel 2024 : 35,2 M€ Entech publie son chiffre d'affaires annuel 2024 sur 9 mois, avec progression significative d'Entech Solutions et contrat record. Stratégie de croissance rentable affirmée pour 2025 Chiffre D'affaires Entech Stratégie De Croissance Progression Contrat Record
Published on 01/30/2026 at 08:35, 2 hours 39 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 3 hours 14 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 8 hours 59 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 11 hours 14 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 12 hours 14 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/30/2026 at 10:08, 1 hour 5 minutes ago Désastreux pour le climat et l'économie: auto-suisse critique sévèrement le refus d'assouplir les prescriptions CO2
Published on 01/30/2026 at 10:00, 1 hour 14 minutes ago Appointment of Managing Director of Tradegate BSX
Published on 01/30/2026 at 09:00, 2 hours 13 minutes ago Original-Research: 123fahrschule SE (von NuWays AG): BUY
Published on 01/30/2026 at 09:00, 2 hours 13 minutes ago Original-Research: q.beyond AG (von NuWays AG): BUY
Published on 01/30/2026 at 08:30, 2 hours 44 minutes ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
Published on 01/30/2026 at 08:00, 3 hours 14 minutes ago AMA : Chiffre d'affaires du 4ème trimestre et de l'année 2025
Published on 01/29/2026 at 18:30, 16 hours 44 minutes ago ALPOU - Groupe POULAILLON chiffre d'affaires trimestriel T1 2025-2026 et Focus sur les activités